Events & News

CytoNiche, HeXun Biosciences & Level Biotechnology Establish Strategic Partnership for Large-Scale MSC Manufacturing

Sep 24,2026

CytoNiche, HeXun Biosciences & Level Biotechnology Establish Strategic Partnership for Large-Scale MSC Manufacturing

CytoNiche’s 3D FloTrix™ platform enables automated MSC manufacturing at tens-of-billions scale through a new tripartite partnership in Taiwan.

>

CytoNiche’s 3D RecomTrix™ Recombinant Collagen Microcarriers Complete U.S. FDA DMF and MF Filings

Aug 17,2026

CytoNiche’s 3D RecomTrix™ Recombinant Collagen Microcarriers Complete U.S. FDA DMF and MF Filings

>

CytoNiche Biotech at KSSCR 2026

Jul 22,2026

CytoNiche Biotech at KSSCR 2026

>

ACTO – Asian Cellular Therapy Organization

Jul 28,2026

ACTO – Asian Cellular Therapy Organization

>

From China's First Approved Stem Cell Therapy to Its First Exosome Therapeutic IND: CytoNiche Continues to Advance the Industrialisation of MSC-Derived Therapies

Jul 08,2026

From China's First Approved Stem Cell Therapy to Its First Exosome Therapeutic IND: CytoNiche Continues to Advance the Industrialisation of MSC-Derived Therapies

CytoNiche supports China's first exosome therapeutic IND, following its first approved stem cell therapy, advancing scalable MSC and exosome manufacturing.

>

CytoNiche's Official Statement on the miniSPIN Series

Jul 02,2026

CytoNiche's Official Statement on the miniSPIN Series

The statement outlines CytoNiche's position on product authenticity, intellectual property, and authorised distribution, and provides guidance on identifying genuine 3D FloTrix™ miniSPIN™ series products.

>

< 12345 >

We are always looking forward to hear from you.

Security verification
Submit Your Request